Trademark: 79324985
Word

Status
Registered
Status Code
700
Status Date
Tuesday, January 31, 2023
Serial Number
79324985
Registration Number
6966095
Registration Date
Tuesday, January 31, 2023
Mark Type
2000
Filing Date
Tuesday, July 6, 2021
Published for Opposition
Tuesday, November 15, 2022

Trademark Owner History
SEEGENE, INC. - Original Registrant

Classifications
44 Medical and diagnostic services, namely, diagnosing in the nature of in vitro diagnostic services for medical purposes; healthcare; health counselling; providing health information in the field of health assessment services; physical examination services; hospital services, not including dentistry services; medical clinic services, not including dentistry services; medical screening and examining services for disease prevention of cancer, infectious disease by pathogens and genetic disease by mutation to improve health culture; telemedicine services, not including dentistry services; medical testing services, namely, medical diagnostic testing; rental of medical and health care equipment; medical assistance services; medical consultation services, not including dentistry services; genetic testing for medical purposes; medical equipment rental; providing collected and managed medical information and personal health information; providing health information services, not including dentistry services; health care business through the Internet, namely, providing online healthcare services; health management consulting business through the Internet namely, providing online healthcare services; healthcare services through the Internet; clinical test in the nature of diagnostic testing and genetic testing for medical treatment purposes and information services related thereto; clinical pathology examination in the nature of medical examination services; medical cancer testing for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes; health center services; medical screening and examining services for disease prevention of cancer, infectious disease by pathogens and genetic disease by mutation; performing diagnosis of diseases; pharmaceutical advice; pharmacy advice in the field of preparation of prescriptions in pharmacies; providing medical information relating to diagnostic, prophylactic and therapeutic properties of medical products; providing medical information relating to diagnostic, prophylactic and therapeutic properties of medical products via the Internet; telemedicine services; medical services; medical information services provided via the Internet; medical and pharmaceutical consultation; medical analysis services relating to the treatment of persons, namely, analysis of human bodily fluid and tissue samples for diagnostic and treatment services provided by a medical laboratory
42 Research and development of DNA chips; structural and functional analysis of genomes; biotechnological research; advisory services relating to biotechnological research; biological services, namely, testing and analysis of biological samples in research laboratories; biological research; crude drugs research; biochemical analysis; biochemical research; research and development in the field of special testing using genetic engineering; research in the field of gene analysis; genetic research; chemical analysis; research in the field of chemistry; chemical research and analysis; chemical research; engineering surveying; technology project research in the field of medical and diagnostic testing; technological research in the field of medical and diagnostic testing; research and development of new products for others; research and development of vaccines and medicines; research on adult diseases; bacteriological research; scientific research for medical purposes in the field of cancerous diseases; research relating to medicines; pharmaceutical products evaluation; consultancy pertaining to pharmacology; medical research in relation to diagnostic testing for identifying hereditary risk factors; medical research in relation to diagnostic testing for evaluating clinical trial progress; medical research in relation to diagnostic testing for preventing illness; medical research in relation to diagnostic testing services; medical research in relation to diagnostic testing services for predicting disease; testing of pharmaceuticals; pharmaceutical research; medical research; medical laboratory services, namely, preparation and analysis of human body tissue and fluid samples, providing reports respecting the same; medical science research in the field of clinical pathology and special examination; scientific research in the nature of conducting clinical trials for others
The mark consists of the stylized design of an X-shaped chromosome at an angle, appearing inside the outline of a circle.

Trademark Events
May 30, 2023
Final Decision Transaction Processed By Ib
May 4, 2023
Final Disposition Notice Sent To Ib
May 4, 2023
Final Disposition Processed
Apr 30, 2023
Final Disposition Notice Created, To Be Sent To Ib
Jan 31, 2023
Notice Of Registration Confirmation Emailed
Jan 31, 2023
Registered-Principal Register
Nov 15, 2022
Official Gazette Publication Confirmation E-Mailed
Nov 15, 2022
Published For Opposition
Oct 26, 2022
Notification Of Notice Of Publication E-Mailed
Oct 10, 2022
Approved For Pub - Principal Register
Oct 10, 2022
Examiner's Amendment Entered
Oct 10, 2022
Notification Of Examiners Amendment E-Mailed
Oct 10, 2022
Examiners Amendment E-Mailed
Oct 10, 2022
Examiners Amendment -Written
Oct 3, 2022
Preliminary/Voluntary Amendment - Entered
Oct 3, 2022
Teas Voluntary Amendment Received
Sep 9, 2022
Teas/Email Correspondence Entered
Sep 9, 2022
Correspondence Received In Law Office
Sep 9, 2022
Teas Response To Office Action Received
Jun 6, 2022
Refusal Processed By Ib
May 17, 2022
Non-Final Action Mailed - Refusal Sent To Ib
May 17, 2022
Refusal Processed By Mpu
Apr 1, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Mar 31, 2022
Non-Final Action Written
Mar 25, 2022
Assigned To Examiner
Nov 12, 2021
Application Filing Receipt Mailed
Nov 8, 2021
New Application Office Supplied Data Entered
Nov 4, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24